IMMUNITOR Ltd. logo — Immunitor's proprietary technology enables us to formulate a...

IMMUNITOR Ltd.

Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill.

Founded 2020 United Kingdom Winchester, United Kingdom 7 employees Biotechnology, Health Care +1

General Information

Company Name IMMUNITOR Ltd.
Founded Year 2020
Location United Kingdom Winchester, United Kingdom
Employees 7
Industries Biotechnology, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with IMMUNITOR Ltd.. To contact IMMUNITOR Ltd., visit immunitor.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About IMMUNITOR Ltd.

IMMUNITOR Ltd. is a biotechnology startup based in the United Kingdom, specializing in formulating vaccines as oral pills. Their proprietary technology allows for easy administration, low manufacturing cost, stability, safety, and effectiveness of vaccines in pill form. Established in 2000, it is a subsidiary of Company Immunitor Inc., with GMP manufacturing capability currently in Thailand. Immunitor has successfully developed and manufactured seven products focusing on preventing and treating various viral infections such as HIV, hepatitis B and C, influenza, cancer, atherosclerosis/obesity, and a broad spectrum of bacterial and fungal infections. These specific immunity products are registered in several Asian and African countries. The company's innovative approach to vaccine delivery and their range of products targeting various diseases make them an attractive investment prospect. With a strong track record in developing oral vaccines, IMMUNITOR Ltd. presents itself as a promising player in the healthcare and pharmaceutical industries, poised for further growth and expansion.

Taxonomy: vaccines, oral vaccination, immunotherapy, GMP manufacturing, infectious diseases, HIV treatment, hepatitis treatment, influenza treatment, cancer treatment, atherosclerosis treatment, obesity treatment, global health, pharmaceuticals

No funding data available for IMMUNITOR Ltd. yet.

IMMUNITOR Ltd. Alternatives & Competitors

View All Alternatives
IMMUNITOR Ltd. vs
Poolbeg Pharma plc
Poolbeg Pharma plc United Kingdom

Focused on the development & commercialisation of innovative medicines. Ticker: POLB

Grant
15 employees
Biotechnology, Pharmaceutical
IMMUNITOR Ltd. vs

Supply Vaccines to Eliminate Human Diseases

Post-IPO Equity
209 employees
Biotechnology, Health and Wellness
IMMUNITOR Ltd. vs
RetroVirox Inc.
RetroVirox Inc. United States

The Virology CRO serving all your antiviral needs

Grant
4 employees
Biotechnology, Health Care

FAQ About IMMUNITOR Ltd.

Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill.
IMMUNITOR Ltd. was founded in 2020.
IMMUNITOR Ltd. is headquartered in Winchester, United Kingdom.
IMMUNITOR Ltd. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on vaccines, oral vaccination, immunotherapy and GMP manufacturing.
IMMUNITOR Ltd. has approximately 7 employees.
Top alternatives and competitors to IMMUNITOR Ltd. include Poolbeg Pharma plc, SINOVAC BIOTECH LTD., RetroVirox Inc., IMUTEX Ltd, ACM Biolabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IMMUNITOR Ltd. and Poolbeg Pharma plc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for IMMUNITOR Ltd., https://bouncewatch.com/company/immunitor-ltd, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes